首页> 外文OA文献 >185: Efficient Stem Cell Mobilization in Lenalidomide Treated Multiple Myeloma Patients Can Be Achieved by Mobilization with DCEP (Dexamethasone, Cyclophosphamide, Etoposide, Cisplatinum) followed by High-Dose G-CSF

【2h】

185: Efficient Stem Cell Mobilization in Lenalidomide Treated Multiple Myeloma Patients Can Be Achieved by Mobilization with DCEP (Dexamethasone, Cyclophosphamide, Etoposide, Cisplatinum) followed by High-Dose G-CSF

机译：185：通过用DCEP（地塞米松，环磷酰胺，依托泊苷，顺铂）和大剂量G-CSF进行动员，可以实现来那度胺治疗的多发性骨髓瘤患者的有效干细胞动员

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Badin S.M.; Lendvai N.; Gounder S.K.; Rowley S.; Donato M.; Goldberg S.; Pecora A.; McBride L.H.; Schmidt L.; Donadio K.A.; McNeil A.; Siegel D.S.;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma | Haematologica [J] . A Corso, L Arcaini, S Caberlon, Haematologica . 2002,第10期

机译：与高剂量环磷酰胺相比，地塞米松，环磷酰胺，依托泊苷和顺铂联合治疗多发性骨髓瘤的外周血干细胞动员毒性小，效果更好。血液学
2. Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSF [J] . ChaudharyL., AwanF., CumpstonA., Journal of clinical apheresis. . 2013,第5期

机译：在多发性骨髓瘤患者中，外周血干细胞动员在新的治疗时代中使用培来沙福和G-CSF进行治疗，与低剂量环磷酰胺和G-CSF进行动员相比具有更高的疗效，但成本却更高
3. Comparing Cyclophosphamide with G-CSF and Plerixafor with G-CSF As Stem Cell Mobilization (SCM) Regimens for Multiple Myeloma (MM) Patients: An Evaluation of Mobilization Efficacy and Toxicity [J] . Tan Carlyn Rose C., Pancari Philip A., Ulicny John, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：环磷酰胺与G-CSF和Plerixafor与G-CSF作为多发性骨髓瘤（MM）患者的干细胞动员（SCM）方案的比较：动员功效和毒性的评估
4. MELPHALAN PLUS HIGH-DOSE DEXAMETHASONE IN AL PATIENTS WHO ARE NOT CANDIDATES FOR STEM CELL TRANSPLANTATION [C] . Giovanni Palladini, Vittorio Perfetti, Laura Obici, International Symposium on Amyloidosis . 2005

机译：Melphalan加上患者的高剂量地塞米松，患者不用于干细胞移植的候选者
5. Beta-Adrenergic Receptor Mediated Transcriptional Dysregulation in Hematopoietic Stem and Progenitor Cells Leads to Bone Marrow Erythroid Suppression in Multiple Myeloma Patients - ex vivo Investigations [D] . Subramaniam, Vimal. 2021

机译：β-肾上腺素能受体介导的造血干细胞和祖细胞中的转录失调导致多发性骨髓瘤患者的骨髓红细胞抑制 - 以外的研究
6. A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma [O] . R Silvennoinen, P Anttila, M Säily, -1

机译：来那度胺诱导多发性骨髓瘤后仅用环磷酰胺+ G-CSF或G-CSF进行干细胞动员的随机II期研究
7. Cost and Outcome Analysis of Autologous Peripheral Blood Stem Cell Mobilization with Plerixafor and G-CSF vs. Cyclophosphamide and G-CSF in Patients with Multiple Myeloma: A Reassessment in View of Increased Costs of Cyclophosphamide [O] . Christopher Chun Man Chen, Christopher Campen, Ali McBride, 2016

机译：具有多骨瘤患者的基磷脂和G-CSF与G-CSF与G-CSF与环磷酰胺和G-CSF的成本和结果分析：鉴于环磷酰胺成本的重新评估

185: Efficient Stem Cell Mobilization in Lenalidomide Treated Multiple Myeloma Patients Can Be Achieved by Mobilization with DCEP (Dexamethasone, Cyclophosphamide, Etoposide, Cisplatinum) followed by High-Dose G-CSF

著录项

引文网络

相似文献

相关主题

期刊订阅